Sequence Similarity Clusters for the Entities in PDB 1KXV

Entity #1 | Chains: A,B
ALPHA-AMYLASE, PANCREATIC protein, length: 496 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 3 17 2514
95 % 3 17 2804 Flexibility: Low
Max RMSD: 1.4, Avg RMSD: 0.5
PDBFlex
90 % 3 17 2865
70 % 17 79 591
50 % 18 83 605
40 % 18 92 591
30 % 18 92 588
Entity #2 | Chains: C,D
CAMELID VHH DOMAIN CAB10 protein, length: 121 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 30457
95 % 1 1 26529 Flexibility: No
Max RMSD: 0.5, Avg RMSD: 0.5
PDBFlex
90 % 1 1 25581
70 % 1 1 29851
50 % 79 617 6
40 % 367 5883 1
30 % 444 7321 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 5IMM 1 B Nanobody 9835
10 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
11 5NLU 1 A single domain llama antibody Nb36 9844
12 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
13 5IMK 1 B Nanobody 9835
14 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
15 4B50 1 A 2H10 LLAMA VHH 9844
16 2XT1 2 B CAMELID VHH 9 30538
17 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
18 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
19 5J1S 3 C VHH domain BS-2 30538
20 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
21 5J1T 3 C VHH domain BS-2 30538
22 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
23 2X1O 1 A, B GELSOLIN NANOBODY 9844
24 4QGY 1 A, B nanobody n25, VH domain 9844
25 5C2B 1 H scFv 3B4 heavy chain 9606
26 5VNV 1 A Nb.b201 32630
27 5DXW 1 A PD-L1 nanobody 10090
28 4N9O 2 B Nanobody Nb484 Nb484 9844
29 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
30 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
31 1T2J 1 A M12-Variable Heavy domain 9606
32 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
33 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
34 5VM6 1 A single domain camelid nanobody VHH T10 9844
35 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
36 4KML 2 B Nanobody 9844
37 4Z9K 2 B VHH2(F5) antibody 30538
38 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
39 5LMW 1 A Nanobody 9844
40 5NM0 1 A, B, C, D Nb36 9844
41 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
42 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
43 4PPT 1 A Engineered single domain VHH antibody 9844
44 3R0M 1 A, B Llama VHH A12 9844
45 3ZKQ 2 D XA4813 9844
46 4I13 2 B Protein ca1697 (nanobody) 9844
47 5C2U 1 B Nanobody Nanobody 9838
48 1XFP 1 A heavy chain antibody VHH domain 9838
49 4POY 1 A VHH-metal 9844
50 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
51 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
52 5NLW 1 A nanobody Nb36 9844
53 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
54 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
55 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
56 3G9A 2 B Minimizer 9838
57 2P43 2 B ANTIBODY CAB-RN05 9838
58 4KRN 1 A Nanobody/VHH domain EgA1 9844
59 4GFT 2 B Nanobody 9844
60 4TVS 2 a, b VHH Domain BS-1 30538
61 4W6Y 2 B Nanobody NbFedF9 9844
62 6EZW 1 B VHH antibody BCD090-M2 9844
63 1UAC 2 H Ig VH,anti-lysozyme 10090
64 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
65 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
66 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
67 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
68 5O02 2 C Nanobody (VHH) Nano-4 30538
69 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
70 4X7F 2 C, D Nano-25 Nanobody 30538
71 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
72 4LGR 2 B Camelid nanobody (VHH3) 30538
73 5J57 2 B VHH single chain antibody V5E1 30538
74 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
75 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
76 5OMM 2 C Nanobody (VHH) Nano-14 30538
77 5E03 1 A mouse CTLA-4 nanobody 10090
78 5LZ0 1 A, B PorM nanobody 9844
79 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
80 2XXC 1 B CAMELID VHH 9 30538
81 3QYC 1 A, B VH domain of IgG molecule 9606
82 5VAK 2 B Nb914 Nanobody 9844
83 2XXM 2 B CAMELID VHH 9 30538
84 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
85 5JDS 1 B Nanobody 9835
86 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
87 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
88 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
89 5L21 2 B VHH-C2 30538
90 5FWO 1 A NANOBODY 9844
91 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
92 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
93 3B9V 1 A, B, C, D heavy chain variable domain 9606
94 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
95 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
96 5N88 1 A, H VH59 antibody 9606
97 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
98 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
99 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
100 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
101 4POU 2 B VHH Antibody 9844
102 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
103 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
104 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
105 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
106 2P42 2 B, D ANTIBODY CAB-RN05 9838
107 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
108 4QLR 1 A, B Llama nanobody n02 VH domain 9844
109 5J56 2 B VHH single chain antibody V1C7 30538
110 4NBX 2 B A20.1 VHH 9844
111 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
112 4HEP 2 G vHH17 domain 9844
113 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
114 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
115 5IML 2 B Nanobody 9835
116 3A6C 2 H IG VH, anti-lysozyme 10090
117 2DQD 2 H Ig VH,anti-lysozyme 10090
118 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
119 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
120 3A67 2 H IG VH, anti-lysozyme 10090
121 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
122 1J1X 2 H Ig VH,anti-lysozyme 10090
123 5M2J 2 D Anti-(ED-B) scFV 9606
124 2DQC 2 H Ig VH,anti-lysozyme 10090
125 1J1O 2 H Ig VH,anti-lysozyme 10090
126 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
127 4M62 2 H, I GEP2 FV heavy chain 9606
128 5IVO 1 A BC2-nanobody 30538
129 1J1P 2 H Ig VH,anti-lysozyme 10090
130 4NBZ 2 B, D A26.8 VHH 9844
131 5AYU 2 H Ig VH,anti-lysozyme 10090
132 3A6B 2 H IG VH, anti-lysozyme 10090
133 2DQJ 2 H Ig VH,anti-lysozyme 10090
134 5F21 2 B nanobody MU375 9844
135 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
136 2P44 2 B ANTIBODY CAB-RN05 9838
137 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
138 5TP3 1 A, B F-VHH-4 9844
139 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
140 4LHJ 2 B Camelid antibody 30538
141 4BEL 2 D, E XA4813 9844
142 5M7Q 1 A, B Nanobody NbD2 9838
143 5H8D 1 A VHH nanobody 9844
144 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
145 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
146 3DUR 2 B, D Ig-like protein 10090
147 2XV6 2 B, D CAMELID VHH 9 30538
148 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
149 5VM0 1 A, B Camelid Nanobody VHH T9 9844
150 4ZG1 1 A, B, C, D, E, F NB17 9844
151 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
152 4I1N 2 B Protein ca1697 (nanobody) 9844
153 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
154 6F0D 1 A, B VHH antibody BCD090-M2 9844
155 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
156 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
157 4W6X 2 B Nanobody NbFedF7 9844
158 5JA9 2 A, B Nanobody 6 9844
159 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
160 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
161 1OP9 1 A HL6 camel VHH fragment 9838
162 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
163 4LRN 1 H GEP 1 heavy chain 9606
164 4S11 1 A GELSOLIN NANOBODY 9844
165 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
166 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
167 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
168 6APQ 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
169 1SHM 1 A, B, D, E ANTIBODY RIG RIG VHH 9844
170 1G7H 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
171 4Y7M 1 A, B Hi113 protein 9844
172 5JMO 2 C, D camelid VHH fragment 9838
173 1A7O 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
174 1KIR 2 B MONOCLONAL ANTIBODY D1.3 10090
175 4B5E 1 A, B PS2-8 9844
176 2DQE 2 H Ig VH,anti-lysozyme 10090
177 1DVF 2 B FV D1.3 IGG1, KAPPA 10090
178 1DVF 4 D FV E5.2 IGG1, KAPPA 10090
179 1G7M 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
180 4X7C 2 C, D Nano-85 Nanobody VHH 30538
181 1OAU 1 H, I, J, K IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
182 3EBA 1 A CAbHul6 9838
183 3ZHD 1 A, B MG8-4 SCAFFOLD ANTIBODY HUMAN HEAVY CHAIN DOMAIN 9606
184 1A6W 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
185 1A7R 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
186 5VM4 1 A, B, C, D, E, F, G, H, I, J, K, L Single domain camelid nanobody VHH T10 9844
187 1WZ1 2 H Ig heavy chain Fv fragment(residues 1-123) 10090
188 4I0C 2 C, D cAbHuL5 antibody 9838
189 1A7P 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
190 1XIW 4 D, H immunoglobulin heavy chain variable region 10090
191 5NGV 2 H anti-human ActRIIB mAb BYM338 heavy-chain C-terminal His6-tag VH 9606
192 1A7Q 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
193 5BOP 1 A, C Nanobody 9844
194 4DKA 1 A, B single domain antibody VHH 9844
195 5O05 1 C, D Nanobody (VHH) Nano-42 30538
196 1OHQ 1 A, B IMMUNOGLOBULIN FV FRAGMENT, RESIDUES 1-120 9606
197 1DSF 2 H ANTICANCER ANTIBODY B1 FV 10090
198 3DUU 2 B, D Ig-like protein 10090
199 3K74 2 B Nanobody 9844
200 5M15 2 C, D Synthetic nanobody L2_D09, (a-MBP#3) 32630
201 1KIP 2 B MONOCLONAL ANTIBODY D1.3 10090
202 2EIZ 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
203 1SJV 1 A r9 llama VHH single domain antibody 9844
204 4M3J 1 A, B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
205 5VL2 1 A, B, C, D, E, F, G, H T4 nanobody 9844
206 2UZI 1 H ANTI-RAS FV HEAVY CHAIN 9606
207 1UA6 2 H Ig VH,anti-lysozyme 10090
208 1IC7 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
209 4W68 1 A, B Single domain antibody 9844
210 1JTT 1 A Vh Single-Domain Antibody VH domain fragment 9838
211 1CFV 2 H MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
212 3EAK 1 A, B NbBCII10-FGLA 9838
213 1KXT 2 B, D, F IMMUNOGLOBULIN VHH FRAGMENT 9838
214 4ORZ 3 C single domain antibody sdAb19 9844
215 4UU9 1 A, H MEDI7814 VARIABLE DOMAIN HEAVY CHAIN 9606
216 6EY6 2 I, J, K, L, M, N, O, P nb130 9844
217 2VYR 2 E, F, G, H, I, J, K, L HUMAN SINGLE DOMAIN ANTIBODY 9606
218 1G7L 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
219 1BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
220 5C1M 2 B Nanobody 39 9844
221 5F7K 2 C, D Nanobody Nb-ER19 9844
222 5LMJ 1 A, B, C, D nanobody 9844
223 5E1H 2 B F8(JOB10) VHH antibody 30538
224 1F2X 1 K, L ANTIBODY HEAVY CHAIN 9838
225 4OCM 3 C, F Nb1 9844
226 5HDO 1 A, B, C, D Anti-HCV NS3/4A serine protease immoglobulin heavy chain 9838
227 1A6U 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
228 4X7E 2 C, D Nano-85 Nanobody 30538
229 5F1O 2 B nanobody MU551 9844
230 1ZV5 2 A immunoglobulin heavy chain antibody variable domain VHH D2-L29 9838
231 5O03 2 C, D Nanobody (VHH) Nano-32 11983
232 2DQI 2 H Ig VH,anti-lysozyme 10090
233 4Y8D 2 C, D nanobody 9844
234 3CX5 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
235 4EIZ 2 C, D Nb113 Camel antibody fragment 9844
236 1I3U 1 A ANTIBODY VHH LAMA DOMAIN 9844
237 1I3V 1 A, B ANTIBODY VHH LAMA DOMAIN 9844
238 4C58 2 B NANOBODY 9844
239 5B8C 2 B, E, H, K Pembrolizumab heavy chain variable region (PemVH) 9606
240 3DV6 2 B Ig-like protein 10090
241 4LAJ 3 H, I, L, M Llama single domain antibody, JM4 9844
242 2EKS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
243 5VXM 2 B Single-domain antibody 20ipaD 30538
244 4XVJ 2 H antibody heavy chain variable domain 9606
245 4IDL 1 A Single Domain Antibody VHH A9 9844
246 1JV5 2 B Ig chain heavy chain precursor V region 9606
247 1FVC 2 B, D IGG1-KAPPA 4D5 FV (HEAVY CHAIN) 9606
248 3K7U 1 A Antibody 9844
249 4Z0X 2 B Antibody HC26AM heavy chain variable domain 9606
250 1IC5 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
251 4NBY 2 B, C A20.1 VHH 9844
252 4X7D 2 C, D Nano-85 Nanobody VHH 9844
253 5VAN 2 B Nb914 Nanobody 9844
254 5F7N 2 C, D Nanobody Nb-ER19 30538
255 5OCL 1 A, C, F, H anti-llama nanobody 30538
256 5OCL 2 B, D, E, G anti-vglut nanobody 9844
257 4LAS 1 H Single heavy chain Variable fragment Heavy chain 10090
258 2A9M 2 H, I fluorescein-scfv heavy chain 9606
259 5E5M 2 B, D, F, H mouse anti CTLA-4 nanobody 10090
260 1SJX 1 A immunoglobulin VH domain 9844
261 3ZKS 2 D XA4813 9844
262 1A6V 2 H, I, J B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
263 5MY6 2 B Nanobody 2Rs15d 9838
264 3DUS 2 B, D Ig-like protein 10090
265 5NH3 2 H, I anti-human ActRIIB mAb BYM338 Fv heavy-chain 9606
266 5M2I 2 G, H, I, J, K, L VHH1 9844
267 5MWN 2 D, E, F llama nanobody raised against TssK, nbK18 9844
268 5MWN 3 N llama nanobody raised against TssK, nbK27 9844
269 3ZHK 1 A, B MG2X1 SCAFFOLD ANTIBODY 9606
270 3K1K 2 C, D Enhancer 9838
271 4U7S 1 A, B sdAb A3 9844
272 4U3X 1 A, C Human VH domain antibody 9606
273 4W81 1 A Single Domain Antibody 9844
274 5GRV 1 L homo-specific diabody heavy chain 9606
275 5JMR 1 A, B camelid VHH fragment 9838
276 4W70 1 A Single Domain Antibody 9844
277 2GSG 2 B, D monoclonal antibody heavy chain variable domain 10090
278 5TBD 1 A, D, E, J Fv fragment (mAb4D1) heavy chain 10090
279 4BFB 2 D, E XA4813 9844
280 5DHV 1 A Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
281 5DHV 3 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
282 43C9 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
283 1NMB 3 H FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
284 5LHR 2 B Camelid-Derived Antibody Fragment Nb22 30538
285 1I8I 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
286 1OAR 1 H, I, J, K IMMUNOGLOBULIN E FV, RESIDUES 1-122 10090
287 4LHQ 2 B, D Camelid nanobody 30538
288 3DV4 2 B Ig-like protein 10090
289 3ZKX 2 B XA4813 9844
290 3ZKX 3 C XA4815 9844
291 5F1K 2 C, D nanobody MU1053 9844
292 3ZLQ 2 C, D XA4813 9844
293 1I3G 2 H ANTIBODY FV FRAGMENT VH DOMAIN 10090
294 1DL7 2 H PROTEIN (ANTIBODY M3C65 (HEAVY CHAIN)) FV (SINGLE CHAIN) 10090
295 4NC0 2 B A26.8 VHH 9844
296 1OCW 1 H IMMUNOGLOBULIN E FV REGION, RESIDUES 1-121 10090
297 1IGM 2 H IGM-KAPPA POT FV (HEAVY CHAIN) 9606
298 5GS1 2 B, N, P, R heavy chain 9606
299 5F7Y 3 C, D Nanobody Nb-ER19 9844
300 2DQG 2 H Ig VH,anti-lysozyme 10090
301 5IMO 1 B Nanobody 9835
302 5U65 1 A, B VHH-5 9838
303 4TYU 1 A, B Single Domain Antibody 9844
304 43CA 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
305 2DQH 2 H Ig VH,anti-lysozyme 10090
306 4AQ1 2 B, D NBKB6 VHH 9844
307 6FV0 2 F nanobody 9844
308 4EIG 2 B CA1698 camel antibody fragment 9844
309 3EHB 3 C FV fragment Chain H 10090
310 6B20 3 E, F Nanobody against G protein beta gamma dimer 9844
311 3HB3 3 C ANTIBODY FV FRAGMENT 10090
312 4FFY 2 H DENV1-E111 single chain variable fragment (heavy chain) 10090
313 2X89 1 A, B, C ANTIBODY 9838
314 5M2M 2 D, E, F, H, J, N Llama nanobody VHH3 9844
315 5O04 2 E, F Nanobody (VHH) Nano-26 30538
316 5O04 3 C, D Nanobody (VHH) Nano-85 30538
317 5LBS 2 H, I BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 ScFv fragment, heavy chain 9606
318 3P9W 2 B, D, F, H human VEGF 9606
319 1AP2 2 B, D MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
320 5F8R 2 C, D Nanobody Nb-ER19 9844
321 1IC4 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
322 4OCL 3 C, F Nb1 9844
323 4RAV 2 A, C single-chain Fv, VH 9606
324 5XJ4 2 H durvalumab-VH 9606
325 5LWY 2 H V REGION HEAVY CHAIN 10090
326 1KB9 10 J HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
327 4X4X 1 A, C Human Variable Heavy Chain of Herceptin 9606
328 4IOS 2 D, E, F, G Llama nanobody 11 9844
329 5LHN 2 B Camelid-Derived Antibody Fragment Nb7 30538
330 2BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
331 2IBZ 10 X Variable Heavy chain of antibody fragment 10090
332 4C57 2 C, D NANOBODY 9844
333 3ZHL 1 A MG8-14 SCAFFOLD ANTIBODY 9606
334 4OCN 3 C, F Nb1 9844
335 4GRW 3 E, G Nanobody 124C4 9844
336 4GRW 4 F, J Nanobody 37D5 9844
337 4GRW 5 H, I Nanobody 22E11 9844
338 5G5R 2 B NANOBODY NB330 SELECTED FROM LLAMA GLAMA 9844
339 4NC2 2 B B39 VHH 9844
340 2WZP 2 D, E, F, J, K, L CAMELID VHH5 9844
341 5LHQ 2 B Camelid-Derived Antibody Fragment Nb7 30538
342 1WT5 1 A, B ANTI EGFR ANTIBODY FV REGION VH fragment 9606
343 6EY0 2 E, G, H llama nanobody nb01 9844
344 6EY0 3 F llama nanobody nb01 9844
345 1JHL 2 H IGG1-KAPPA D11.15 FV (HEAVY CHAIN) 10090
346 5F9A 2 C Nanobody Nb-ER19 9844
347 4LLV 1 A, C, E, H 4E10 Fv heavy chain 9606
348 4LAR 1 H Single heavy chain variable fragment Heavy Chain 10090
349 5CBA 1 A, C 3b4 heavy chain 9606
350 5VXJ 2 B, D, F, H, J single-domain antibody JMK-E3 30538
351 1A14 2 H NC10 FV (HEAVY CHAIN) VH DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
352 1C08 2 B ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VH FRAGMENT 10090
353 2OTW 2 B, D Fv heavy chain variable domain VH 10090
354 3STB 1 A, B single domain antibody VHH 9844
355 2YSS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
356 4W6W 2 B NbFedF6 9844
357 5JA8 2 B, D, F, H Nanobody 2 9844
358 2YBR 1 A, D, G SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN, RESIDUES 1-117 9606
359 2BJM 1 H IGE SPE7 HEAVY CHAIN ANTHRONE ATTACHED HEAVY CHAIN, RESIDUES 1-120 10090
360 1P4B 2 H Antibody Variable heavy chain 10090
361 5U4M 2 B V1C7 VHH antibody 30538
362 5O0W 2 E, F, G, H Nb474 30538
363 4Y5V 1 A, D, G diabody 305 VH domain 9606
364 1DQL 2 H IGM MEZ IMMUNOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN FRAGMENT 9606
365 1JTO 1 A, B Vh Single-Domain Antibody VH domain fragment 9838
366 3V0A 3 C Llama antibody F12 9844
367 5F97 2 E, F, G, H Nanbody Nb-ER19 9844
368 3K80 1 A, B Antibody 9844
369 5VAQ 2 B Nb914 Nanobody 9844
370 1QD0 1 A VHH-R2 ANTI-RR6 ANTIBODY VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
371 5F8Q 2 C, D Nanobody Nb-ER19 9844
372 4U05 1 A, B Single Domain Antibody 9844
373 5F9D 2 C Nanobody Nb-ER19 9844
374 4X4Y 1 A, C Human Variable Heavy Chain of Herceptin 9606
375 4LGP 2 B, D VHH1 camelid nanobody 30538
376 2P48 2 B ANTIBODY CAB-RN05 9838
377 5U4L 2 B V1C7 VHH antibody G29R variant 30538
378 5VXK 1 B single-domain antibody JMK-H2 30538
379 5F7M 2 C, D Nanobody Nb-ER19 9844
380 5DA4 1 A, B, C Nanobody recognizing the membrane protein SLC26Dg 9844
381 5F7W 2 C, D Nanobody Nb-ER19 9844
382 4YQX 1 H, N JES6-1 VH domain 10116
383 1EZV 10 X HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
384 3U6R 1 A, H Antibody 1:7 (Heavy chain) 9606
385 1NMC 2 B, H SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
386 1MEL 1 A, B VH SINGLE-DOMAIN ANTIBODY 9838
387 4NC1 2 C, D A20.1 VHH 9844
388 4NC1 3 E, F A26.8 VHH 9844
389 5M30 2 D, E, F Anti-vesicular stomatitis virus N VHH 30538
390 4WEU 1 D, E Anti-F4+ETEC bacteria VHH variable region 9844
391 2DQF 2 B, E Ig VH,anti-lysozyme 10090
392 5E7F 1 A, B, C nanobody L06 9838
393 2P46 2 B, D ANTIBODY CAB-RN05 9838
394 3CXH 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
395 5YOY 3 G, H, I, P, Q, R Golimumab heavy chain variable region 9606
396 5LWF 2 C, D Camelid heavy-chain antibody variable fragment cAb-G10S 9844
397 5LHP 2 B Camelid-Derived Antibody Fragment 30538
398 5USF 2 C, D Immunoglobulin heavy chain variable region 9844
399 1P84 10 J Heavy Chain (Vh) Of Fv-Fragment 10090
400 5SV4 1 A, B Single Domain Antibody A3C8 9844
401 4LGS 2 B Camelid nanobody (VHH4) 30538
402 3QXV 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
403 2XTJ 4 D FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-131 9606
404 5CBE 1 A, C E10 heavy chain 9606
405 2P47 2 B ANTIBODY CAB-RN05 9838
406 4KRM 2 B, D, F, H, J, L Nanobody/VHH domain 7D12 9844
407 3WXW 2 H V region heavy chain 10090
408 3K3Q 1 A llama Aa1 VHH domain 9844
409 4P2C 3 G, H, I, J, K Nanobody 1, Anti-F4+ETEC bacteria VHH variable region 9844
410 1AR1 3 C ANTIBODY FV FRAGMENT 10090
411 3EZJ 2 B, D, F, H NANOBODY NBGSPD_7 9844
412 5VNW 2 C, D Nb.b201 32630
413 1BVK 2 B, E HULYS11 FV 9606
414 6FE4 2 F, G, H, I, J Nb113 30538
415 5NML 1 A, B, C, D, E, F, G, H, I, J Nanobody Nb36 Ser85Cys 9844
416 2CJU 1 H NQ16-113.8 ANTI-PHOX ANTIBODY 10090
417 5HVF 2 B VHH-i83 30538
418 1P4I 2 H antibody variable heavy chain 10090
419 4PGJ 1 A, C Human heavy chain domain antibody 9606
420 4KDT 1 A, B Nanobody24 9835
421 3CFI 3 C, F, I, L Nanobody NBEPSIJ_11 9844
422 2VH5 1 H ANTI-RAS FV HEAVY CHAIN 9606
423 4S10 1 A, B GELSOLIN NANOBODY GELSOLIN NANOBODY 9844
424 5MJE 2 B Nanobody 8 9844
425 3LH2 2 H, I, J, K Fv 4E10 heavy chain 9606
426 3OGO 2 E, F, G, H GFP-nanobody 9838
427 4C59 2 B NANOBODY 9844
428 5VXL 2 B single-domain antibody JPS-G3 30538
429 1OAZ 2 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
430 4DK6 1 A, B single domain antibody VHH 9844
431 5F93 2 C, D, F, H Nanobody Nb-ER19 9844
432 5F7L 2 B, D Nanobody Nb-ER14 9844
433 1OAY 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
434 5HVG 2 B, D VHH-a204 30538
435 4LAQ 1 H Single heavy chain variable fragment Heavy chain 10090
436 3UPC 1 A, B, C, D, E, F, G, H, I, J heavy chain variable domain 9606
437 4W2Q 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
438 5HVH 2 B VHH-a204 30538
439 5HVH 3 C VHH-i83 30538
440 4XT1 3 C nanobody 7 30538
441 5LXG 2 H V REGION HEAVY CHAIN 10090
442 5HM1 1 A, B, C lama VHH antibody 2E7 9844
443 5FUC 3 E, V VHH6 9838
444 4RZC 1 A, C, E, H Fv M6P-1 light chain 9986
445 3H3P 1 H, I Fv 4E10 heavy chain 9606
446 5O2U 2 B, D VHH 59H10 9844
447 5SV3 1 A, C Anti-Ricin A-chain Single Domain Antibody (sdAb) A3C8 9844
448 3NN8 1 A, C, D, G Engineered scFv, heavy chain 10090
449 5OMN 2 C Nanobody (VHH) Nano-27 30538
450 4KRP 2 B Nanobody/VHH domain 9G8 9844
451 1OAX 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
452 6FUZ 2 N nanobody 9839
453 4FHB 2 D Nb179 9844
454 4DK3 1 A, B single domain antibody VHH 9844
455 4KRL 1 B Nanobody/VHH domain 7D12 9844
456 4V1D 1 A SINGLE CHAIN ANTIBODY FRAGMENT LR, HEAVY CHAIN 9606
457 4V1D 4 D SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN 9606
458 1BZQ 2 K, L, M, N PROTEIN (ANTIBODY CAB-RN05) VARIABLE DOMAIN 9838
459 1NMA 3 H FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
460 1YZZ 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 9838
461 4LDE 2 B Camelid Antibody Fragment 9844
462 4Y5Y 1 A, D diabody 330 VH domain 9606
463 5DMJ 2 B, E, G 3H65-5 domain antibody (dAb) 9606
464 1BVL 1 A, C HULYS11 FV 10090
465 3RJQ 2 B Llama VHH A12 9844
466 1ZMY 1 A Antibody cabbcII-10:lys3 N-terminus, 142 residues 9838
467 3AB0 2 B, E antibody ScFv fragment, heavy chain 10090
468 3LHP 1 H, I Fv 4E10 heavy chain 9606
469 4N1H 2 B, D Camelid heavy-chain antibody variable fragment cAb-F11N 9844
470 6CK9 2 D 35O22 scFv heavy chain portion 9606
471 6EQI 2 B Nb696 9844
472 2BSE 2 D, E, F LLAMA IMMUNOGLOBULIN VHH RECOGNITION DOMAIN, RESIDUES 1-123 9844
473 1YC8 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33-hu 9838
474 4KFZ 2 C, D Anti-LMO2 VH 9606
475 2UUD 1 H, J NQ10-1.12 ANTI-PHOX ANTIBODY 10090
476 5TOJ 2 D, E, F Single-domain antibody F-VHH-4 9844
477 4Y5X 1 A, D, G, J diabody 310 VL domain 9606
478 4YGA 2 B, D, F, H VHH-1B7 30538
479 4UT9 2 H, I, J, K BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, HEAVY CHAIN DOMAIN 9606
480 2A9N 2 H, I fluorescein-scfv heavy chain 9606
481 5GS0 3 D, F heavy chain (anti-TLR3) 10090
482 5GS0 4 H, X heavy chain (anti-Lid) 10090
483 5G5X 2 B NANOBODY NB330, SELECTED FROM LLAMA, C-TERMINAL 6XHIS- TAG 9844
484 1KYO 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT RESIDUES 1-127 10090
485 5GRJ 1 H avelumab H chain 9606
486 4NKD 1 A, C, E, G Engineered scFv heavy chain 10090
487 5BOZ 2 G, H, I, J, K, L VHH single chain antibody E1 30538
488 4KRO 2 B Nanobody/VHH domain EgA1 9844
489 3WXV 2 H V region heavy chain 10090
490 4KV5 2 E, G, H, J heavy chain GC1009 scFv 9606
491 3DWT 1 A, B, C, D, E, F, G, H cAbBCII-10 9838
492 5TJW 2 K NP-specific inhibitory VHH 30538
493 1QLE 5 H HEAVY CHAIN ANTIBODY FV FRAGMENT 10090
494 4LDL 2 B Camelid Antibody Fragment 9844
495 4LDO 2 B Camelid Antibody Fragment 9844
496 5XJ3 1 A, D, G, J ipilimumab-VH 9606
497 3SN6 5 N Camelid antibody VHH fragment 9844
498 5M94 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
499 4M8Q 1 A, H GEP1 Fv heavy chain 9606
500 5NHR 2 A, H Bimagrumab Fv heavy-chain VH 9606
501 4W2O 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
502 5O8F 2 K, O Nanobody Nb25 9844
503 5O8F 3 L, M, N Nanobody Nb25 9844
504 5NQW 2 C, D 026 9844
505 5C3L 4 D Nanobody Nb15 Nanobody 9838
506 5J3H 2 C mAb 83-7 Fab heavy chain 10090
507 5U8R 2 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
508 1G6V 2 K ANTIBODY HEAVY CHAIN CAB-CA05, VARIABLE DOMAIN 9838
509 5UK4 2 a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition mofiv and HIS TAG 30538
510 5FV2 1 A, B, C VH DOMAIN ANTIBODY VH DOMAIN ANTIBODY 9606
511 4WGV 2 B, D Camelid antibody fragment, nanobody 9844
512 5OJM 2 K, L, M, N, O Nanobody Nb25 9844
513 6B73 2 C, D Nanobody 9844
514 4PIR 2 F, G, H, I, J VHH15 9844
515 5XWD 2 H VH chain of 059-152 9606
516 6C5W 2 C, E nanobody 562
517 4QKX 2 B R9 protein 9844
518 5JQH 2 C, D Nanobody60, Nb60 9844
519 4YBQ 3 D, F antibody Fv fragment heavy chain 10090
520 4PD4 10 J Igh protein 10090
521 5DA0 2 B Nanobody 9844
522 4R0L 1 A, H Antibody 1C6 Heavy chain 10090
523 5U8Q 3 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
524 3P0G 2 B Camelid Antibody Fragment NANOBODY 9844
525 4ODX 2 A, H GEP7 Fv heavy chain 9606
526 5M95 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
527 4WGW 2 B, D Camelid antibody fragment, nanobody 9844
528 1RVF 6 H FAB 17-IA 10090
529 5JZ7 2 C, G, H, J MEDI578 scFv, heavy chain 9606
530 5IHL 2 B, E, G, I 3H56-5 domain antibody (dAb) 3H56-5 dAb 9606
531 4MQS 2 B Nanobody 9-8 9844
532 5DHY 1 A, H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
533 5WB2 3 D nanobody B1 32630
534 1QFW 4 H ANTIBODY (ANTI ALPHA SUBUNIT) (HEAVY CHAIN) FV 10090
535 1QFW 6 I ANTIBODY (ANTI BETA SUBUNIT) (HEAVY CHAIN) FV 10090
536 3K81 2 A, B Single strand antibody VHH domain single domain antibody VHH 9844
537 4OGA 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
538 4MQT 2 B Nanobody 9-8 9844
539 5TOK 2 D, E, F Single-domain antibody F-VHH-L66 9844
540 4NKM 1 A, C, E, G Engineered scFv heavy chain 10090
541 3W11 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
542 4NKO 2 B, D, F Engineered scFv heavy chain 10090
543 5EUL 4 V AYC08 30538
544 5GXB 2 B nanobody 30538
545 5NBD 2 C Nanobody 9844
546 3W13 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
547 3W12 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
548 5H8O 1 A VHH nanobody 9844
549 4KSD 2 B R2 protein 9844
550 5DHZ 1 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
551 2A0L 3 D, F 33H1 Fv fragment Fv fragment, heavy chain 10090
552 5DFZ 4 E Nanobody binding S. cerevisiae Vps34 9844
553 5UKB 1 a, b, c, d, e Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition motif and HIS tag. 30538
554 5WDU 2 D, O, W bnAb NIH45-46 scFv heavy chain 9606
555 5TD8 5 E nanobody 30538
556 6CUE 3 3, H, h vFP7.04 Heavy chain 10090
557 6CUE 5 5, M, m PGT122 heavy Chain 9606
558 6CUE 7 7, Q, q VRC03 Heavy chain 9606
559 6CDI 4 5, M, m PGT122 Heavy Chain 9606
560 6BSP 1 A U4 Heavy chain 10090
561 6B3J 6 N Nanobody 35 9844
562 6EHG 3 C hC3Nb1 9844
563 5Y0A 2 D, F, H variable region of Fab ZKA190 heavy chain 9606
564 5XS7 2 H Heavy chain of Fab 1D5 10090
565 5W3L 5 E C5 antibody variable heavy domain 10090
566 5W3M 1 E C5 antibody variable heavy domain 10090
567 5W3O 1 D C5 antibody variable heavy domain 10090
568 5W3E 1 E C5 antibody variable heavy domain 10090
569 5VAI 6 N nanobody 35 9844
570 5UZ7 4 N NANOBODY 35 9844
571 5TSJ 10 1, 2 Human heavy chain domain antibody 9606
572 5TR1 2 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
573 5TQQ 3 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
574 5H32 2 G, I, K C10 IgG heavy chain variable region 9606
575 5H37 3 G, I, K C10 IgG heavy chain variable region 9606
576 5H30 3 G, I, K IgG C10 heavy chain 9606
577 5KWL 4 7 VHH 10E 9838
578 5KTZ 4 7 VHH 12B 9838
579 5KU0 4 7 VHH 17B 9838
580 5KU2 4 7 VHH 7A 9838
581 5KEL 3 H, P, Q c2G4 variable Fab domain heavy chain 9606
582 5KEL 5 C, J, M c13C6 variable Fab domain heavy chain 9606
583 5KEM 2 B, G BDBV91 variable Fab domain heavy chain 9606
584 5KEM 3 D, I c13C6 variable Fab domain heavy chain 9606
585 5KEN 3 C, G, N c4G7 variable Fab domain heavy chain 9606
586 5KEN 6 J, Q c13C6 variable Fab domain heavy chain 9606
587 3JCX 2 H Fab E heavy chain 10116
588 5FOJ 1 A NANOBODY 9838
589 3JBC 5 7 nanobody VHH PVSP29F 9838
590 3JBD 5 7 nanobody VHH PVSP6A 9838
591 3JBE 5 7 nanobody VHH PVSS8A 9838
592 3JBF 5 7 nanobody VHH PVSP19B 9838
593 3JBG 5 7 nanobody VHH PVSS21E 9838
594 3JBA 2 H H16.U4 antibody heavy chain Fab variable domain 10090
595 3JAU 2 H Heavy chain of Fab fragment variable region of antibody D5 10090
596 5A1Z 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
597 4UIF 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 9606
598 4UIH 2 D, F ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -HEAVY CHAIN 9606
599 4UDF 4 11, 15, 19, 1D, 1H, 1L, 1P, 1T, 1X, 21, 25, 29, 2D, 2H, 2L, 2P, 2T, 2X, 31, 35, 39, 3D, 3H, 3L, 3P, 3T, 3X, 41, 45, 49, 4D, 4H, 4L, 4P, 4T, 4X, 51, 55, 59, 5D, 5H, 5L, 5P, 5T, 5X, 61, 65, 69, 6D, 6H, 6L, 6P, 6T, 6X, 7D, 7H, 7L, 7P, 7T, 7X HUMAN MONOCLONAL ANTIBODY 9606
600 3J8Z 3 F, G, H, I H16.1A heavy chain variable domain Fab 10090
601 3J8V 3 F, G, H, I H16.14J heavy chain variable domain Fab 10090
602 3J8W 2 F, G, H, I H263.A2 heavy chain variable domain Fab 10090
603 3J7E 2 B, D, F, H H16.V5 Fab heavy chain variable domain 10090
604 3J6U 3 H Fab 5J7 heavy chain variable region 9606
605 4CKD 2 H, I, J, K SCFV13R4 ANTIBODY FV HEAVY CHAIN 10090
606 3IY1 2 B Fab B, heavy chain 10116
607 3IY2 2 B Antibody 6, heavy chain FRAGMENT OF ANTIBODY 6 10090
608 3IY3 2 B antibody fragment from neutralizing antibody 8 (heavy chain) 10090
609 3IY4 2 B fragment of neutralizing antibody 15 (heavy chain) 10090
610 3IY5 2 B antibody fragment IGG2A (heavy chain) 10090
611 3IY6 2 B fragment from neutralizing antibody E (heavy chain) 10116
612 3IY7 2 B fragment from neutralizing antibody F (heavy chain) 10116
613 3IY0 2 H Fab 14, heavy domain 10090
614 1IEH 1 A BRUC.D4.4 SINGLE DOMAIN ANTIBODY FROM A NAIVE LLAMA LIBRARY 9844
615 1G9E 1 A H14 9844
616 1QNZ 1 H 0.5B ANTIBODY (HEAVY CHAIN) FV 10090
617 1VHP 1 A VH-P8 9606